相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Co-delivery of cisplatin and doxorubicin by covalently conjugating with polyamidoamine dendrimer for enhanced synergistic cancer therapy
Xue-Ling Guo et al.
ACTA BIOMATERIALIA (2019)
The reversal of multidrug resistance in ovarian carcinoma cells by co-application of tariquidar and paclitaxel in transferrin-targeted polymeric micelles
Wanting Zou et al.
JOURNAL OF DRUG TARGETING (2017)
Smart chemistry-based nanosized drug delivery systems for systemic applications: A comprehensive review
Thiruganesh Ramasamy et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Facile construction of bioreducible crosslinked polypeptide micelles for enhanced cancer combination therapy
Hima Bindu Ruttala et al.
ACTA BIOMATERIALIA (2017)
Synergistic Cisplatin/Doxorubicin Combination Chemotherapy for Multidrug-Resistant Cancer via Polymeric Nanogels Targeting Delivery
Haiqiu Wu et al.
ACS APPLIED MATERIALS & INTERFACES (2017)
Engineering of cell microenvironment-responsive polypeptide nanovehicle co-encapsulating a synergistic combination of small molecules for effective chemotherapy in solid tumors
Thiruganesh Ramasamy et al.
ACTA BIOMATERIALIA (2017)
Global Cancer Incidence and Mortality Rates and Trends-An Update
Lindsey A. Torre et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2016)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Revisiting the role of nanoparticles as modulators of drug resistance and metabolism in cancer
Pranav Gupta et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2016)
Reversal of Chemoresistance in Ovarian Cancer by Co-Delivery of a P-Glycoprotein Inhibitor and Paclitaxel in a Liposomal Platform
Yilin Zhang et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Telodendrimer nanocarrier for co-delivery of paclitaxel and cisplatin: A synergistic combination nanotherapy for ovarian cancer treatment
Liqiong Cai et al.
BIOMATERIALS (2015)
Magnetite (Fe3O4)-filled carbon nanofibers as electro-conducting/superparamagnetic nanohybrids and their multifunctional polymer composites
Arindam Das et al.
JOURNAL OF NANOPARTICLE RESEARCH (2015)
Upregulation of PD-LI and APEI is associated with tumorigenesis and poor prognosis of gastric cancer
Yi Qing et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2015)
Synthesis, characterization and bifunctional applications of bidentate silver nanoparticle assisted single drop microextraction as a highly sensitive preconcentrating probe for protein analysis
Lokesh Shastri et al.
RSC ADVANCES (2015)
Systemic delivery of axitinib with nanohybrid liposomal nanoparticles inhibits hypoxic tumor growth
Ju Yeon Choi et al.
JOURNAL OF MATERIALS CHEMISTRY B (2015)
Tariquidar inhibits P-glycoprotein drug efflux but activates ATPase activity by blocking transition to an open conformation
Tip W. Loo et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Liposomes as carriers of hydrophilic small molecule drugs: Strategies to enhance encapsulation and delivery
Josimar Oliveira Eloy et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2014)
JWA reverses cisplatin resistance via the CK2-XRCC1 pathway in human gastric cancer cells
W. Xu et al.
CELL DEATH & DISEASE (2014)
Liposomal drug delivery systems: From concept to clinical applications
Theresa M. Allen et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
The Effect of Nanoparticle Size, Shape, and Surface Chemistry on Biological Systems
Alexandre Albanese et al.
ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, VOL 14 (2012)
Three Decades of P-gp Inhibitors: Skimming Through Several Generations and Scaffolds
A. Palmeira et al.
CURRENT MEDICINAL CHEMISTRY (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Reversal of multidrug resistance by co-delivery of tariquidar (XR9576) and paclitaxel using long-circulating liposomes
Niravkumar R. Patel et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)
Tumor-homing multifunctional nanoparticles for cancer theragnosis: Simultaneous diagnosis, drug delivery, and therapeutic monitoring
Kwangmeyung Kim et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance
Yogesh Patil et al.
JOURNAL OF CONTROLLED RELEASE (2009)
Tariquidar (XR9576): a P-glycoprotein drug efflux pump inhibitor
Elizabeth Fox et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2007)
Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance
Changping Wu et al.
ACTA HISTOCHEMICA (2006)
Mechanisms of Taxol resistance related to microtubules
GA Orr et al.
ONCOGENE (2003)
Paclitaxel Resistance: Molecular Mechanisms and Pharmacologic Manipulation
R. Z. Yusuf et al.
CURRENT CANCER DRUG TARGETS (2003)
Liposomes as sustained release system for human interferon-γ:: biopharmaceutical aspects
ML Van Slooten et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2001)
分享论文
